Skip to content

Clinical trials

Phase 3 Dermatitis, Atopic trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 3 Country / region: Belgium Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20131
20161
20189
20191
20211
20222
20234
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Active, not recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
LEO Pharma6
Amgen4
AbbVie3
Astellas Pharma Inc3
Incyte Corporation2
Pfizer2
Regeneron Pharmaceuticals2
Almirall, S.A.1
Eli Lilly and Company1
Galderma R&D1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic25
Eczema8
Dermatitis1
Genetic Diseases, Inborn1
Hypersensitivity1
Hypersensitivity, Immediate1
Immune System Diseases1
Pruritus1
Skin Diseases1
Skin Diseases, Eczematous1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.